DEHYDROEPIANDROSTERONE (DHEA) - ANVISA Registration 10230730177
Access comprehensive regulatory information for DEHYDROEPIANDROSTERONE (DHEA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10230730177 and manufactured by DRG INTERNATIONAL, INC.. The registration is held by NL COMรRCIO EXTERIOR LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including LDN LABOR DIAGNOSTIKA NORD GMBH & CO., MONOBIND, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10230730177
25351638007202263
52541273000147
Company Information
Dates and Status
Jan 16, 2023
VIGENTE
09/18/2025 19:00:01
DEHIDROEPIANDROSTERONA (DHEA)
DHEA Test System โ ELISA
MONOBIND, INC
80048490102
Dec 23, 2024
DEHIDROEPIANDROSTERONA (DHEA)
EIA-3415 DHEA ELISA
DRG INSTRUMENTS GMBH
81905510079
May 08, 2023
DEHIDROEPIANDROSTERONA (DHEA)
Dehidroepiandrosterona (DHEA) ELISA
EUROIMMUN AG
10338930241
Dec 10, 2020
DEHIDROEPIANDROSTERONA (DHEA)
DHEA Saliva ELISA
IBL INTERNATIONAL GMBH
80500080014
Dec 10, 2020
DEHIDROEPIANDROSTERONA (DHEA)
DHEA ELISA
IBL INTERNATIONAL GMBH
80500080011
Sep 24, 2020

